From the Sanford-Burnham Medical Research Institute Press Release: Researchers discover mutations in a protein that plays a role in the body’s DNA repair system—similar to what’s observed in the rare children’s disease ataxia-telangiectasia. The discovery provides an approach to identifying therapies that will resuscitate the broken DNA repair mechanism. Newswise — LA JOLLA, Calif., March … Read More
Using brain imaging technology, researchers at the University of Nottingham, United Kingdom, are working on a way to develop biomarkers for ataxia-telangiectasia that may enable and accelerate future clinical trials. Biomarkers are indirect measures of the underlying disease process that can help to assess whether or not drugs work. Drs. Robert Dineen and Dorothee Auer … Read More
As a founding member of the Global Alliance for Genomics and Health (GA4GH), the A-T Children’s Project joins 148 organizations and institutions to meet the challenge of sharing genomic and clinical data to advance human health. Analyzing large amounts of genomic data will help researchers find treatments for both common and rare disorders. At the … Read More
The A-T Children’s Project is distributing a 16-page handbook called Caring for People with Ataxia-Telangiectasia. Topics include: Neurology Managing Lung Health Immunology Vaccine Schedules Cancer School Recommendations This handbook draws on the extensive experience of the clinicians who focus on A-T at The Johns Hopkins Hospital in Maryland, the hundreds of families who have been to … Read More
Dear friend of the A-T Children’s Project, As you plan your year-end charitable contributions, here are some reasons why I’m hoping you’ll include us in these final 24 hours: 1. With your help we’ve made real progress. To date, our greatest pay-off has come in extending the average lifespan of A-T kids by nearly eight years through … Read More
The A-T Children’s Project hosted a small, two-day workshop in Boston, Massachusetts entitled “Optimizing Cancer Management in A-T.” Clinical oncologists and immunologists from around the world gathered to discuss what is known, and what needs to be learned, about caring for patients with A-T who develop cancer. About 25 percent of children with A-T develop … Read More
Over 250 A-T CureTeam runners completed either 5K, 10K, Half Marathon, or inaugural Dumbo Double Dare (10K and Half Marathon) over Labor Day weekend, lacing up to help fund research to find a cure for A-T. At the pasta dinner on Saturday night, Mickey and Minnie joined the crowd of nearly 500 people for photos. … Read More
David Cox, MD, PhD was the first director of the A-T Children’s Project’s Scientific Advisory Board and has remained an advisor for the past 20 years. He always gave generously of his time and expertise, whether attending meetings, reviewing grants, brainstorming ideas, or providing candid advice. His leadership and friendship helped guide our research program, … Read More
IN HONOR OF OUR FRIEND JOE Read More
Brad Margus has been tapped to co-chair the oversight board for the Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, a new, innovative program at the National Institutes of Health. NeuroNEXT, will provide a robust, standardized, and expert network of 25 clinical centers across the USA to more quickly test treatments for adults and … Read More
